|Other names||6-[1'-Ethyl-2',2'-dimethyl-3'-hydroxy]propyl-β-naphthol-2-benzyl ether|
|Drug class||Nonsteroidal estrogen|
|Chemical and physical data|
|Molar mass||348.486 g·mol−1|
|3D model (JSmol)|
SC-4289 is a synthetic nonsteroidal estrogen which, along with mytatrienediol (SC-6924; Manvene, Anvene), was developed in the late 1950s as a potential treatment for atherosclerosis in men but was never marketed.
|This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.|